Kunal is currently Vice President and Head of Business Development at Synthekine, a role he has held since October 2020. He has over 15 years of experience, serving as both an operator in and an advisor to life sciences companies at all stages, guiding strategic decisions and investments for licenses and acquisitions, internal R&D pipelines, commercial launches, and product lifecycle management. Prior to joining Synthekine, Kunal worked in business development and strategic planning roles spanning multiple therapeutic areas at Harpoon Therapeutics and Genentech/Roche. He started his career as a management consultant in the life sciences practice of Deloitte Consulting. Kunal holds a B.S. and M.S. in Bioengineering from University of California, Berkeley and University of Pennsylvania, respectively, and also received an MBA from Columbia Business School.